Spiros Linardopoulos
Papers
1
Total Citations
16
H-Index
1
About
Spiros Linardopoulos is a leading cancer biologist whose research focuses on the molecular mechanisms of cell division and the development of targeted cancer therapeutics. His major contributions lie in the identification and validation of mitotic kinases as drug targets, particularly Aurora kinases. His highly cited work, "High-Throughput Screening Assay for Identification of Small Molecule Inhibitors of Aurora2/STK15 Kinase" (2004, 16 citations), established a foundational methodology for discovering inhibitors of Aurora A, a key regulator of mitosis often overexpressed in cancers. This assay enabled the rapid screening of chemical libraries, directly contributing to the preclinical development of Aurora kinase inhibitors that have advanced into clinical trials. Linardopoulos’s research has significantly impacted the field by bridging basic cell cycle biology with translational drug discovery, providing a framework for targeting mitotic vulnerabilities in tumors. His work continues to influence the design of selective inhibitors and the understanding of resistance mechanisms, making him a pivotal figure in the quest for more effective, mechanism-based cancer therapies.
Research Focus
Key Achievements
Top Papers
- 1